U.S. market Closed. Opens in 5 hours 31 minutes

GSK | GSK plc Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for GSK we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is wealthy, Growth is bad and Health is weak.

Valuation (66%)

Company Industry
P/E Ratio (TTM) 29.28 47.55
PEG Ratio (TTM) -2.95 2.54
P/S Ratio (TTM) 1.88 8.68
P/B Ratio (TTM) 8.22 24.85
P/FCF Ratio (TTM) 12.51 -44.63
Price to 5YR AVG Earnings Ratio 29.20 59.12
Price to 5YR AVG FCF Ratio 14.59 89.13

Profitability (65%)

Company Industry
ROA (TTM) 6.95% 6.43%
ROE (TTM) 29.50% 30.90%
Net Profit Margin (TTM) 12.83% 13.10%
ROIC 5YR AVG 20.90% 20.65%

Growth (42%)

4QTR AVG 3YR AVG 5YR AVG
EPS 31.70% -6.07% -5.83%
Revenue 2.71% 3.53% -0.01%
Net Income 31.26% 9.42% 8.12%
Cash Flow 7.27% -1.77% -5.29%

Health (49%)

Company Industry
Current Ratio (TTM) 0.82 1.11
Quick Ratio (TTM) 0.54 0.88
D/E Ratio (TTM) 1.18 3.19
Interest Coverage (TTM) 9.37 14.83
Piotroski F-Score 7 6
Altman Z-Score 2.02 4.79
LTL to 5YR AVG FCF 2.70 4.03
Shares Outstanding Growth 5YR AVG 21.75% 1.17%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙